QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability for up to five targets No ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced financial results for the fourth quarter and ...

Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...

QIAGEN has introduced two tools designed to advance microbial analysis by allowing researchers to customise their assays and panels. These tools are compatible with QIAcuity digital polymerase ...

Q4 2024 Management View Thierry Bernard, CEO, highlighted that Qiagen surpassed its Q4 2024 sales and adjusted earnings targets, with net sales reaching $521 million at 3% CER growth, exceeding the ...

Qiagen, a Netherlands-based leading global provider of Sample to Insight solutions, announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more ...

Net sales of $525 million CER ahead of outlook for at least $520 million CER and adjusted diluted EPS of $0.61 CER ahead of outlook for at least $0.60 CER QIAstat-Dx, QuantiFERON and QIAcuity ...